跳至主要内容
临床试验/NCT04339127
NCT04339127Unknown不适用

Study of 12 Cases of Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis and Review of the Literature

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
12
试验地点
1
主要终点
Details of clinical, biological, imaging, therapeutic characteristics and patient's evolution.

研究概览

简要总结

Herpes Simplex Virus encephalitis is the most common infectious encephalitis, with an estimated annual incidence of 1 / 250,000 to 1 / 500,000 in industrialized countries. Despite a widely used antiviral treatment, the prognosis remains poor with a mortality of 5 to 20% and a considerable morbidity rate.

One of the contributing factors of bad prognosis is the development of encephalitis mediated by autoantibodies, most often directed against NMDA receptors, in the weeks following viral encephalitis.

The description of this pathology is recent, the pathophysiology of this process remains poorly understood, and the management of these patients is not yet codified.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical autoimmune encephalitis with anti-NMDA antibodies and documented by CBA in the CSF
  • After a herpetic encephalitis documented by a positive viral PCR for HSV in the CSF
  • Without age limit
  • Exclusion Criteria- No respect of inclusion criteria

排除标准

  • 未提供

结局指标

主要结局

Details of clinical, biological, imaging, therapeutic characteristics and patient's evolution.

时间窗: at 6 and 12 months

Retrospective collection of clinical, diagnostic and therapeutic data, evolution at 6 and 12 months.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Autoimmune Encephalitis With Anti-NMDA Receptor... | 临床试验